NCT00851578已完成不适用
ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 8
- 主要终点
- Feasibility study to characterize the performance of the WATCHMAN LAA Closure device in atrial fibrillation patients contracindicated to warfarin treatment
研究概览
简要总结
The purpose of the study is to characterize the performance of the WATCHMAN LAA Closure Device in atrial fibrillation patients for which long term warfarin therapy is contraindicated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or older
- •paroxysma, persistent, or permanent non-vlavular atrial fibrillation
- •contraindicated to warfarin
- •eligible for clopidogrel, ticlopdine, heparin, or aspirin
- •CHADS score 1 or greater
排除标准
- •NYHA Class IV
- •LAA obliteration
- •Heart transplant
- •LVEF less than 30%
- •greater than 50% carotid stenosis
结局指标
主要结局
Feasibility study to characterize the performance of the WATCHMAN LAA Closure device in atrial fibrillation patients contracindicated to warfarin treatment
时间窗: 2 years
次要结局
未报告次要终点
研究者
研究点 (8)
Loading locations...
相似试验
已完成
不适用
Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)Atrial FibrillationNCT01196897Boston Scientific Corporation69
已完成
不适用
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)Non-valvular Atrial FibrillationNCT02654470Boston Scientific Corporation300
已完成
不适用
Registry on WATCHMAN Outcomes in Real-Life UtilizationPatients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, StrokeNCT01972282Boston Scientific Corporation1,025
终止
不适用
Observational Study of the LMA ProtectorAirway Complication of AnesthesiaNCT03664700Oxford University Hospitals NHS Trust112
招募中
不适用
Lifetech LAmbre™ Left Atrial Appendage Closure System Post-Market RegistryAtrial FibrillationNCT04307927Lifetech Scientific (Shenzhen) Co., Ltd.100